Autism Spectrum Disorder
📧 Sign up to get email alerts when something new happens for Autism Spectrum Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Intranasal Oxytocin and Learning in Autism [Phase 2]
Phase 2 trial investigating intranasal oxytocin and learning in autism completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: A Study of the Elopement Prevention and Safety Training Program [NA]
A clinical trial evaluating the Elopement Prevention and Safety Training Program conducted at Emory University has completed.
-
FDA approval · 2017-03-29FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' supplemental application for aripiprazole, enabling the marketing of a generic aripiprazole product.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: An Open-Label Study of N-Acetyl Cysteine in Children With Autism [Phase 2]
Open-label Phase 2 study evaluating N-acetylcysteine in children with autism has completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: A Study of Pregnenolone in the Treatment of Individuals With Autism [Phase 2]
A Phase 2 study evaluating pregnenolone for autism spectrum disorder has completed; results were posted in 2017.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behaviors in Autism [Phase 2]
A Phase 2 clinical trial evaluating transcranial magnetic stimulation for evaluation and treatment of repetitive behaviors in autism was ter…
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM) [Phase 2]
Phase 2, multi-site, double-blind, placebo-controlled trial evaluating memantine versus placebo in children with autism has completed. The s…
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: Dose Finding Study of Pioglitazone in Children With Autism Spectrum Disorders (ASD) (PIO) [Phase 2]
A Phase 2 dose-finding clinical trial of pioglitazone in children with autism spectrum disorder has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Evaluating the Validity of an Eye Gaze Paradigm in Predicting Autism Spectrum Disorder
A completed clinical trial conducted at The Cleveland Clinic evaluated whether an eye gaze paradigm can predict autism spectrum disorder. Th…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1) [Phase 2]
A Phase 2 trial evaluating citalopram for repetitive behaviors in children with autism has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Early Detection of Autism Spectrum Disorder in Children
A completed clinical trial from Saint Louis University evaluated early detection of autism spectrum disorder in children. The study identifi…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Trial of Methyl B12 on Behavioral and Metabolic Measures in Children With Autism [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluated methyl B12 (methylcobalamin) for behavioral and metabolic outcomes in children with autism; results wer…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism [NA]
The update reports the completion of a clinical trial evaluating a manualized wireless moisture pager to teach toileting in children with au…
-
FDA approval · 2017-02-23FDA Approved: RISPERIDONE — Supplemental Application (Janssen Pharmaceutical, Inc.)
FDA approved a supplemental application for Risperidone submitted by Janssen Pharmaceutical, Inc. The action pertains to an addition or modi…
-
FDA label_change · 2017-02-23FDA Approved: RISPERDAL — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Risperdal (risperidone) from Janssen Pharmaceuticals, resulting in changes to the product la…
-
FDA approval · 2017-02-23FDA Approved: ARIPIPRAZOLE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application to authorize a generic aripiprazole product by Lannett Company, Inc. under ANDA204171.
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD) [Phase 2]
This update indicates that Roche's RG7314 Phase 2 trial in autism spectrum disorder has completed, evaluating its efficacy and safety.
-
CLINICAL_TRIALS withdrawal · 2017-02-02Clinical Trial Update: Clonidine for Sleep Disturbances in Children With Autism Spectrum Disorder [Phase 2]
A Phase 2 clinical trial evaluating clonidine for sleep disturbances in children with autism spectrum disorder has been withdrawn.
-
FDA approval · 2017-02-01FDA Approved: RISPERIDONE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for risperidone submitted by Ajanta Pharma USA Inc. The approval indicates updated labeling and pote…
-
FDA approval · 2017-02-01FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for aripiprazole (generic ARIPIPRAZOLE) from Amneal Pharmaceuticals LLC, authorizing the generic for…
-
CLINICAL_TRIALS research · 2017-01-24Clinical Trial Update: Hyperthermia and the Amelioration of Autism Symptoms
The clinical trial evaluating hyperthermia for improving autism symptoms has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: Neurophysiological Molecular and Developmental Analysis of the Glutamate Synapse in Autism [NA]
The clinical trial examining neurophysiological and developmental aspects of the glutamate synapse in autism has been completed.
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders [Phase 1]
This document reports a completed placebo-controlled Phase 1 pilot trial of mecamylamine for autism spectrum disorders conducted by Ohio Sta…
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies [NA]
The trial evaluating neurocircuitry in autism with fMRI and transcranial magnetic stimulation was terminated, and results were posted in Jan…
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions [Phase 1]
Phase 1 PET imaging study of an mGluR5 tracer across several neuropsychiatric conditions has been completed.